Diagnos Inc. ("DIAGNOS" or the "Corporation") (TSX Venture: ADK, OTCQB: DGNOF, FWB: 4D4A), a Canadian leader in artificial intelligence (AI) for the ...

A large, prospective study implicates high levels of interleukin 6 with severity of diabetic retinopathy and shows it may be ...

Diagnos Inc. (“DIAGNOS” or the “Corporation”) (TSX Venture: ADK, OTCQB: DGNOF, FWB: 4D4A), a Canadian leader in artificial intelligence (AI) for the early detection of retinal and systemic diseases, ...

PIP and ADP offer weekly support ranging from £29.20 to £187.45, equating to approximately £116.80 or £749.80 every four-week ...

If you have daily living and/or mobility needs due to a sight condition or low vision, you might be eligible for PIP or ADP ...

“The SMART AI application enables ophthalmologists to streamline patient screening, empowers primary care providers to ...

(“Avant” or the“Company”) and its JV partner, Ainnova Tech, Inc., (Ainnova), a leading healthcare technology company focused on revolutionizing early disease detection using artificial intelligence ...

Survival models using electronic health record data show promise in predicting progression to proliferative diabetic ...

A novel AI-powered retina tracker can analyze retinal images with near-perfect accuracy in under one second, according to a ...

In summary, type 2 diabetes can have a big impact on your eyesight, but much of the damage can be prevented with regular ...

Similar data from Social Security Scotland indicates there are now 2,010 people receiving ADP for an eye condition. An estimated 188,000 people in Scotland are affected by some form of sight loss with ...